The Japanese telecommunications holding company SoftBank Group Corp. has announced that it has reached an agreement with Alphabet Inc., the holding company Google is part of, to buy the robots producers Boston Dynamics and Schaft for a figure that hasn’t been disclosed. Google bought the two companies in December 2013 as part of a series of acquisitions in the field of robotics and artificial intelligence but something didn’t go well in its plans, which have been modified.
The ASCO 2017, the annual Meeting of the American Society of Clinical Oncology (ASCO), new data were presented regarding the experimentation of Watson for Oncology, the version of IBM’s cognitive computing system trained to recognize the symptoms of various forms of cancer and suggest a therapy. Developed within the Watson Health business unit, it showed a level of agreement with human doctors that reached 96% in cases of lung cancer.
An article published in the journal “Nature Photonics” describes the development of the first graphene-based camera. A team of researchers from the Institute of Photonic Sciences (ICFO) integrated a CMOS-type circuit with graphene creating a high resolution image sensor consisting of hundreds of thousands of graphens-based photodetectors and quantum dots. The camera is sensitive to ultraviolet, visible and infrared light at the same time.
Hewlett Packard Enterprise (HPE) presented a prototype of “The Machine”, the computer of the future announced in June 2014. It is a single-memory computer, which means it exceeds the division between RAM and mass memory with its 160 TB (TeraByte) memory, more than that of servers. However, this is not a memtor, the technology being developed that should best combine the benefits of RAM and mass memory.
The Wall Street Journal reported the launch of Neuralink, the new Elon Musk company. The restless founder and CEO of SpaceX and Tesla Motors has opened another company to develop a technology that allows to directly connect the human brain to a computer. Neuralink was registered as a medical research company because the project doesn’t have a transhumanist purpose only but also aims to develop treatments for neurological problems.